TEVA deal giving AGN 40 Billion dollars should go through in July 2016 and AGN price should return to $280 to $300 per share
Sentiment: Strong Buy
Check the stats
Well the stock share price is rising and the TEVA deal is on track so I guess we are going higher.
sorry Pfizer is out to the deal, put they are paying Allergan 160 million dollars to walk away. A good Payday for Allergan
Somebody sacrificed 500 shares at the end of the day to knock the ASTC price down to $2.10. They did this so they can pick up another 100,000 shares tomorrow. Smart people are buying.
The unaffected Allergan price prior to the announced Pfizer acquisition implied a multiple of 16-17x. Although Pfizer announced a purchase price that accorded a 19x multiple, we'll disregard that as most acquisitions require a control premium. Prior to the Merger though, Allergan did not have much, if any, takeover premium. It was trading historically in-line with its multiple and as such, the 16-17x is a fair indication of the multiple Allergan would have enjoyed as a standalone company.
Short sellers already hysterical and desperate.
Sentiment: Strong Buy
Buyers are showing up - I will bet Warren Buffet and company are buying
Option traders and short sellers or investor leveraged in AGN could be crushed this week by a rapid change in share price. The air tight lid is sealed completely, and no information is leaking. Nobody knows what will happen.
This can not be good. This may be why many of the original owners are releasing their shares in a secondary offering. Scary.
Sentiment: Strong Sell
The prediction was right. The big shareholders are dumping their shares. Afraid of Hillary Clinton.
Short sellers will be crushed on Friday. Investors should be buying. Read Wall street journal and Barrons to get information on what is going to happen.
Profitable Photonics Business
$500M Business Opportunity
Pipeline over Life of Current Programs
2015 Milestones: Apache at FullVolume
Moving Toward LT Target, Funding
Vehicle Awarded for Next-Generation
IVAC Returning Capital to Shareholders through
$30M Stock Repurchase Program
• $21M Purchased as of Nov 2, 2015 Conf. Call